CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech sectors
AI, Credit, and Our Human Future: A Question of Capability, Not Just Technology
Visibility and value: As AI-generated outpu
TTP releases new e-book on closing the loop in neuromodulation therapy
TTP has released a new e-book exploring how closed-loop neuromodulation systems can deliver more personalised, responsive therapies. It examines the role of clinically meaningful biomarkers, algorithms, and system-level design in turning real-time sensing into reliable treatment. The e-book draws on TTP’s neurotechnology expertise to help teams de-risk development and accelerate next-generation…
Addenbrooke’s unveils transformed urgent and emergency care spaces and digital innovations for winter
Transformed urgent and emergency care areas and a new digital registration and triage tool are part of plans by teams at Cambridge University Hospitals to help patients get the right treatment in the right place as quickly as possible this winter.
Cambridge Dining Co. - crafting exceptional events
CAMBRIDGE DINING CO. — CRAFTING EXCEPTIONAL EVENTS
New IDTechEx Report: Sensor Market 2026-2036
IDTechEx forecasts that the global sensor market will reach US$250B by 2036 as global mega-trends in mobility, AI, robotics, 6G connectivity and IoT drive sensor demand.
Cambridge NeuroWorks drives UK neurotech forward with launch of nationwide Blue Sky Proof-of-Concept Fund
Cambridge NeuroWorks announces a new UK-wide initiative designed to power high-risk, high-impact experimentation in early-stage neurotechnology.
Beta Launch of LYEONS Heart
The Beta Launch of 23 LYEONS Heart devices is now live!
VALANX Biotech establishes Board of Directors
Renowned industry leaders, Michael Boehler, Alexander Schwartz, Urs Spitz and Ingo Nagler, appointed to guide strategic and commercial development
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
ETD001 is well tolerated in healthy individuals at higher doses than predicted to be therapeutic for long-lasting enhancement of mucociliary clearanceResults showed excellent consistency between preclinical and clinical behaviour of ETD001Phase 2 trial
UK health: Focus on prevention can deliver £8 for each £1 invested
UK has the potential to unlock £8 in socio-economic returns for every £1 spent on preventive healthcare, according to new Deloitte analysis; Increasing prevention spend from current 6% to 10% could lead to £42 billion of savings to the UK healthcare system in 10 years; A 7% reduction in preventable deaths could save over 5,400 lives annually, with a societal value of £6 billion.
Life sciences talent development when the half-life of knowledge shrinks
By Excellence First Enterprise Consultancy (EFEC).
Beacon’s Patient Group Mentoring Programme 26 – 27
Become a mentor on Beacon’s Patient Group Mentoring Programme and make a real difference to the rare disease community! Applications are open until the 19th of December.
Lab Thread announces Beta release of Unified Lab Software Platform
Designed to streamline collaboration across biological research, combining real-time data management, analysis, DNA sequence design, chat and review functions within one intuitive, easy to use systemInterested parties invited to register for beta access via the Lab Thre
Guardtech Group sign off record-breaking 2025 in style with a series of ground-breaking projects that are set to protect, preserve and improve human life
The East Anglian cleanroom construction specialists racked up more projects this year than ever before – including some very special life-saving ventures
Royal Papworth Hospital: A lifeline of connectivity during a crisis
Royal Papworth Hospital, located on the Cambridge Biomedical Campus, stands as a world-renowned centre for heart and lung care, serving 4,000 staff, patients, and visitors each day.
SCORES Athlete project relaunches with a fresh design on Mantal
The SCORES Athlete project—focused on understanding long-term health outcomes related to sports participation—has been refreshed and relaunched using Mantal’s modern digital infrastructure to enhance participant engagement and expand study reach.
Cambridge-based business leader Sarah Mardle named on the 2025 UK Kindness and Leadership list
Sarah Mardle, CEO and Founder of Alma Business Consulting, has been recognised on the 2025 UK Kindness and Leadership list, sponsored by the Financial Times, the
Rapsodi & PD-Frontline studies successfully migrate to Mantal
The Rapsodi and PD-Frontline Parkinson’s studies have officially migrated to Mantal, enabling researchers to consolidate study operations, improve participant engagement, and future-proof their digital research infrastructure.
PREDICT-PD, the largest UK cross-sectional Parkinson’s study, adopts Mantal
PREDICT-PD, one of the UK’s most important Parkinson’s research initiatives, is now using the Mantal platform to expand participant reach, streamline digital assessments, and accelerate its mission to identify early markers of Parkinson’s disease.
TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board
Experienced biotech Chair and executive will guide corporate growth and development
